Possible therapeutic value of melatonin in mild cognitive impairment: A retrospective study

Mild Cognitive Impairment: Clinical Characterization and Outcome

Petersen, R. C., Smith, G. E., Waring, S. C., Ivnik, R. J., Tangalos, E. G., & Kokmen, E. (1999) · Archives of Neurology · doi:10.1001/archneur.56.3.303 · Cited by 8,980 · see citing works

Staging of alzheimer's disease-related neurofibrillary changes

Braak, H., & Braak, E. (1995) · Neurobiology of Aging · doi:10.1016/0197-4580(95)00021-6 · Cited by 2,357 · see citing works

Melatonin : a potent, endogenous hydroxyl radical scavenger

Tan, D. (1993) · Endocrine Journal · Cited by 1,659 · see citing works

One molecule, many derivatives: A never-ending interaction of melatonin with reactive oxygen and nitrogen species?

Tan, D., Manchester, L. C., Terron, M. P., Flores, L. J., & Reiter, R. J. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00407.x · Cited by 1,601 · see citing works

Amnestic MCI or prodromal Alzheimer's disease?

Dubois, B., & Albert, M. L. (2004) · The Lancet Neurology · doi:10.1016/s1474-4422(04)00710-0 · Cited by 543 · see citing works

Evolution of neuronal changes in the course of Alzheimer’s disease

Braak, H., & Braak, E. (1998) · Journal of neural transmission. Supplementum · doi:10.1007/978-3-7091-6467-9_11 · Cited by 482 · see citing works

A Multicenter, Placebo-controlled Trial of Melatonin for Sleep Disturbance in Alzheimer's Disease

Singer, C., Tractenberg, R. E., Kaye, J., Schafer, K., Gamst, A., Grundman, M., Thomas, R., & Thal, L. J. (2003) · Sleep · doi:10.1093/sleep/26.7.893 · Cited by 407 · see citing works

A4 amyloid protein deposition and the diagnosis of Alzheimer's disease

Davies, L., Wolska, B., Hilbich, C., Multhaup, G., Martins, R. N., Simms, G., Beyreuther, K. T., & Masters, C. L. (1988) · Neurology · doi:10.1212/wnl.38.11.1688 · Cited by 369 · see citing works

The human pineal gland and melatonin in aging and Alzheimer's disease

Wu, Y., & Swaab, D. F. (2004) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2004.00196.x · Cited by 368 · see citing works

Decreased Melatonin Levels in Postmortem Cerebrospinal Fluid in Relation to Aging, Alzheimer’s Disease, and Apolipoprotein E-ε4/4 Genotype¹

Liu, R.-Y., Zhou, J.-N., van Heerikhuize, J., Hofman, M. A., & Swaab, D. F. (1999) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jcem.84.1.5394 · Cited by 304 · see citing works

Molecular Changes Underlying Reduced Pineal Melatonin Levels in Alzheimer Disease: Alterations in Preclinical and Clinical Stages

Wu, Y., Feenstra, M. G. P., Zhou, J., Liu, R., Toraño, J. S., van Kan, H. J. M., Fischer, D. F., Ravid, R., & Swaab, D. F. (2003) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2003-030833 · Cited by 284 · see citing works

Melatonin secretion rhythm disorders in patients with senile dementia of Alzheimer’s type with disturbed sleep–waking

Mishima, K., Tozawa, T., Satoh, K., Matsumoto, Y., Hishikawa, Y., & Okawa, M. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(97)00510-6 · Cited by 269 · see citing works

Early neuropathological Alzheimer's changes in aged individuals are accompanied by decreased cerebrospinal fluid melatonin levels

Zhou, J., Liu, R., Kamphorst, W., Hofman, M. A., & Swaab, D. F. (2003) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2003.00065.x · Cited by 269 · see citing works

Double Blind Study of Melatonin Effects on the Sleep-wake Rhythm, Cognitive and Non-cognitive Functions in Alzheimer Type Dementia

Asayama, K., Yamadera, H., Ito, T., Suzuki, H., Kudo, Y., & Endo, S. (2003) · Journal of Nippon Medical School · doi:10.1272/jnms.70.334 · Cited by 242 · see citing works

An assessment of the antioxidant and the antiamyloidogenic properties of melatonin: implications for Alzheimer's disease

Pappolla, M. A., Chyan, Y., Pöeggeler, B., Frangione, B., Wilson, G. L., Ghiso, J. A., & Reiter, R. J. (2000) · Journal of Neural Transmission · doi:10.1007/s007020050018 · Cited by 239 · see citing works

Melatonin in Alzheimer's disease and other neurodegenerative disorders

Srinivasan, V. J., Pandi-Perumal, S. R., Cardinali, D. P., Pöeggeler, B., & Hardeland, R. (2006) · Behavioral and Brain Functions · doi:10.1186/1744-9081-2-15 · Cited by 226 · see citing works

Daily variation in the concentration of melatonin and 5-methoxytryptophol in the human pineal gland: effect of age and Alzheimer's disease

Skene, D. J., VIVIEN‐ROELS, B., Sparks, D. L., Hunsaker, J. C., Pévet, P., Ravid, D., & Swaab, D. F. (1990) · Brain Research · doi:10.1016/0006-8993(90)90214-v · Cited by 224 · see citing works

AFMK, a melatonin metabolite, attenuates X‐ray‐induced oxidative damage to DNA, proteins and lipids in mice

Manda, K., Ueno, M., & Anzai, K. (2007) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2007.00432.x · Cited by 222 · see citing works

The potential of melatonin in reducing morbidity–mortality after craniocerebral trauma

y Aibar, M. D. M., Murillo-Cabezas, F., Terrón, M. P., Flores, L. J., Tan, D. X., Manchester, L. C., & Reiter, R. J. (2006) · Journal of Pineal Research · doi:10.1111/j.1600-079x.2006.00376.x · Cited by 191 · see citing works

The use of melatonin in Alzheimer's disease.

Cardinali, D. P., Brusco, L. I., Liberczuk, C., & Furio, A. M. (2002) · PubMed · Cited by 189 · see citing works

Melatonin for treatment of sundowning in elderly persons with dementia – a preliminary study

Cohen‐Mansfield, J., Garfinkel, D., & Lipson, S. (2000) · Archives of Gerontology and Geriatrics · doi:10.1016/s0167-4943(00)00068-6 · Cited by 159 · see citing works

Pineal and pituitary-adrenocortical function in physiological aging and in senile dementia

Ferrari, E., Arcaini, A., Gornati, R., Pelanconi, L., Cravello, L., Fioravanti, M., Solerte, S. B., & Magri, F. (2000) · Experimental Gerontology · doi:10.1016/s0531-5565(00)00160-1 · Cited by 153 · see citing works

Role of melatonin in Alzheimer-like neurodegeneration

Wang, J.-Z., & Wang, Z.-F. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00260.x · Cited by 150 · see citing works

Melatonin effects on sleep, mood, and cognition in elderly with mild cognitive impairment

Jean‐Louis, G., von Gizycki, H., & Zizi, F. (1998) · Journal of Pineal Research · doi:10.1111/j.1600-079x.1998.tb00557.x · Cited by 143 · see citing works

Melatonin treatment stabilizes chronobiologic and cognitive symptoms in Alzheimer's disease.

Brusco, L. I., Márquez, M., & Cardinali, D. P. (2000) · PubMed · Cited by 140 · see citing works

Daily rhythm of serum melatonin in patients with dementia of the degenerate type

Uchida, K., Okamoto, N., Ohara, K., & Morita, Y. (1996) · Brain Research · doi:10.1016/0006-8993(96)00086-8 · Cited by 138 · see citing works

Daily rhythm of serum melatonin levels and effect of light exposure in patients with dementia of the Alzheimer’s type

Ohashi, Y., Okamoto, N., Uchida, K., Iyo, M., Mori, N., & Morita, Y. (1999) · Biological Psychiatry · doi:10.1016/s0006-3223(98)00255-8 · Cited by 133 · see citing works

SUPPLEMENTARY ADMINISTRATION OF ARTIFICIAL BRIGHT LIGHT AND MELATONIN AS POTENT TREATMENT FOR DISORGANIZED CIRCADIAN REST-ACTIVITY AND DYSFUNCTIONAL AUTONOMIC AND NEUROENDOCRINE SYSTEMS IN INSTITUTIONALIZED DEMENTED ELDERLY PERSONS

Mishima, K., Okawa, M., Hozumi, S., & Hishikawa, Y. (2000) · Chronobiology International · doi:10.1081/cbi-100101055 · Cited by 108 · see citing works

The Amyloid β Protein Induces Oxidative Damage of Mitochondrial DNA

Bozner, P., Grishko, V. I., LeDoux, S. P., Wilson, G. L., CHYAN, Y.-C., & Pappolla, M. A. (1997) · Journal of Neuropathology & Experimental Neurology · doi:10.1097/00005072-199712000-00010 · Cited by 107 · see citing works

Melatonin Treatment of Day-Night Rhythm Disturbances and Sundowning in Alzheimer Disease

Mahlberg, R., Kunz, D., Sutej, I., Kühl, K.-P., & Hellweg, R. (2004) · Journal of Clinical Psychopharmacology · doi:10.1097/01.jcp.0000132443.12607.fd · Cited by 96 · see citing works

The neuroprotective activities of melatonin against the Alzheimer β‐protein are not mediated by melatonin membrane receptors

Pappolla, M. A., Simovich, M. J., Bryant‐Thomas, T., Chyan, Y., Pöeggeler, B., Dubocovich, M. L., Bick, R. J., Perry, G. L., Cruz-Sánchez, F., & Smith, M. A. (2002) · Journal of Pineal Research · doi:10.1034/j.1600-079x.2002.1o838.x · Cited by 91 · see citing works

Effects of melatonin in elderly patients with sleep disturbance: a pilot study

Fainstein, I., Bonetto, A., Brusco, L. I., & Cardinali, D. P. (1997) · Current Therapeutic Research · doi:10.1016/s0011-393x(97)80066-5 · Cited by 88 · see citing works

Beneficial effects of melatonin in experimental models of Alzheimer disease1

CHENG, Y., Zheng, F., ZHANG, Q.-Z., & ZHANG, J.-T. (2006) · Acta Pharmacologica Sinica · doi:10.1111/j.1745-7254.2006.00267.x · Cited by 71 · see citing works

Specificity Clusters of MUC1-Reactive Mouse Monoclonal Antibodies

Hanisch, F. (1998) · Tumor Biology · doi:10.1159/000056511 · Cited by 20 · see citing works

Untitled work

Price (1999) · doi:10.1002/1531-8249(199903)45:3

Melatonin—A pleiotropic, orchestrating regulator molecule

Hardeland, R., Cardinali, D. P., Srinivasan, V., Spence, D. W., Brown, G. M., & Pandi-Perumal, S. R. (2011) · Progress in Neurobiology · doi:10.1016/j.pneurobio.2010.12.004 · Cited by 843 · see citing works

Sleep, circadian rhythms, and the pathogenesis of Alzheimer disease

Musiek, E. S., Xiong, D. D., & Holtzman, D. M. (2015) · Experimental & Molecular Medicine · doi:10.1038/emm.2014.121 · Cited by 529 · see citing works

Natural Compounds for Alzheimer’s Disease Therapy: A Systematic Review of Preclinical and Clinical Studies

Andrade, S., Ramalho, M. J., Loureiro, J. A., & Pereira, M. D. C. (2019) · International Journal of Molecular Sciences · doi:10.3390/ijms20092313 · Cited by 240 · see citing works

Is Melatonin the “Next Vitamin D”?: A Review of Emerging Science, Clinical Uses, Safety, and Dietary Supplements

Minich, D. M., Henning, M., Darley, C., Fahoum, M., Schuler, C. B., & Frame, J. (2022) · Nutrients · doi:10.3390/nu14193934 · Cited by 176 · see citing works

Neurobiology, Pathophysiology, and Treatment of Melatonin Deficiency and Dysfunction

Hardeland, R. (2012) · The Scientific World Journal · doi:10.1100/2012/640389 · Cited by 173 · see citing works

Melatonin in mitochondrial dysfunction and related disorders

Srinivasan, V., Spence, D. W., Pandi-Perumal, S. R., Brown, G. M., & Cardinali, D. P. (2011) · International Journal of Alzheimer s Disease · doi:10.4061/2011/326320 · Cited by 100 · see citing works

Loss of response to melatonin treatment is associated with slow melatonin metabolism

Braam, W., Van Geijlswijk, I., Keijzer, H., Smits, M. G., Didden, R., & Curfs, L. M. G. (2010) · Journal of Intellectual Disability Research · doi:10.1111/j.1365-2788.2010.01283.x · Cited by 94 · see citing works

The Effects of Melatonin Treatment on Oxidative Stress Induced by Ovariohysterectomy in DogsPreprint

Salavati, S., Mogheiseh, A., Nazıfı, S., et al. (2020) · Research Square · doi:10.21203/rs.3.rs-123019/v1 · Cited by 3 · see citing works

Serum melatonin levels in melanoma patients after repeated oral administration

Kane, M. A., Johnson, A., Nash, A., Boose, D., Mathai, G., Balmer, C. M., Yohn, J. J., & Robinson, W. A. (1994) · Melanoma Research · doi:10.1097/00008390-199402000-00009 · Cited by 9 · see citing works

Are the proposed benefits of melatonin-rich foods too hard to swallow?

Kennaway, D. J. (2015) · Critical Reviews in Food Science and Nutrition · doi:10.1080/10408398.2014.962686 · Cited by 33 · see citing works

Effects of long-term light, darkness and oral administration of melatonin on serum levels of melatonin

Farhadi, N., Ghareghani, M., & Farhadi, Z. (2016) · Biomedical Journal · doi:10.1016/j.bj.2015.09.003 · Cited by 33 · see citing works